These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 29145599

  • 1. A Role for Thiopurine Metabolites in the Synergism Between Thiopurines and Infliximab in Inflammatory Bowel Disease.
    Mogensen DV, Brynskov J, Ainsworth MA, Nersting J, Schmiegelow K, Steenholdt C.
    J Crohns Colitis; 2018 Feb 28; 12(3):298-305. PubMed ID: 29145599
    [Abstract] [Full Text] [Related]

  • 2. Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
    Holmstrøm RB, Mogensen DV, Brynskov J, Ainsworth MA, Nersting J, Schmiegelow K, Steenholdt C.
    Dig Dis Sci; 2018 Jun 28; 63(6):1583-1591. PubMed ID: 29564674
    [Abstract] [Full Text] [Related]

  • 3. Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy.
    Yarur AJ, Kubiliun MJ, Czul F, Sussman DA, Quintero MA, Jain A, Drake KA, Hauenstein SI, Lockton S, Deshpande AR, Barkin JS, Singh S, Abreu MT.
    Clin Gastroenterol Hepatol; 2015 Jun 28; 13(6):1118-24.e3. PubMed ID: 25562796
    [Abstract] [Full Text] [Related]

  • 4. Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine.
    Armstrong L, Sharif JA, Galloway P, McGrogan P, Bishop J, Russell RK.
    Aliment Pharmacol Ther; 2011 Nov 28; 34(9):1106-14. PubMed ID: 21929546
    [Abstract] [Full Text] [Related]

  • 5. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR, Pierik M, Seinen ML, van Bodegraven AA, Gilissen LP, Bus P, Bakker JA, Masclee AA, Neef C, Engels LG, Hooymans PM.
    J Crohns Colitis; 2014 Feb 28; 8(2):120-8. PubMed ID: 23932783
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
    Gilissen LP, Wong DR, Engels LG, Bierau J, Bakker JA, Paulussen AD, Romberg-Camps MJ, Stronkhorst A, Bus P, Bos LP, Hooymans PM, Stockbrügger RW, Neef C, Masclee AA.
    J Crohns Colitis; 2012 Jul 28; 6(6):698-707. PubMed ID: 22398098
    [Abstract] [Full Text] [Related]

  • 7. The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patients.
    Gao X, Zhang FB, Ding L, Liu H, Wang XD, Chen BL, Bi HC, Xiao YL, Zhao LZ, Chen MH, Huang M, Hu PJ.
    Eur J Gastroenterol Hepatol; 2012 Aug 28; 24(8):958-64. PubMed ID: 22664938
    [Abstract] [Full Text] [Related]

  • 8. Thiopurines and their optimization during infliximab induction and maintenance: A retrospective study in Crohn's disease.
    Luber RP, Dawson L, Munari S, Kariyawasam VC, Martin C, Gibson PR, Sparrow MP, Ward MG.
    J Gastroenterol Hepatol; 2021 Apr 28; 36(4):990-998. PubMed ID: 32881046
    [Abstract] [Full Text] [Related]

  • 9. Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database Study.
    Meijer B, Wilhelm AJ, Mulder CJJ, Bouma G, van Bodegraven AA, de Boer NKH.
    Ther Drug Monit; 2017 Aug 28; 39(4):399-405. PubMed ID: 28489727
    [Abstract] [Full Text] [Related]

  • 10. Association between 6-thioguanine nucleotide levels and preventing production of antibodies to infliximab in patients with inflammatory bowel disease.
    Phillips J, Leary S, Tyrrell-Price J.
    BMJ Open Gastroenterol; 2023 Jun 28; 10(1):. PubMed ID: 37328288
    [Abstract] [Full Text] [Related]

  • 11. Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel Diseases.
    Yarur AJ, Gondal B, Hirsch A, Christensen B, Cohen RD, Rubin DT.
    J Clin Gastroenterol; 2018 Jul 28; 52(6):537-544. PubMed ID: 28723860
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis.
    Wusk B, Kullak-Ublick GA, Rammert C, von Eckardstein A, Fried M, Rentsch KM.
    Eur J Gastroenterol Hepatol; 2004 Nov 28; 16(12):1407-13. PubMed ID: 15618853
    [Abstract] [Full Text] [Related]

  • 13. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
    Gearry RB, Barclay ML, Roberts RL, Harraway J, Zhang M, Pike LS, George PM, Florkowski CM.
    Intern Med J; 2005 Oct 28; 35(10):580-5. PubMed ID: 16207256
    [Abstract] [Full Text] [Related]

  • 14. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy.
    Dervieux T, Meyer G, Barham R, Matsutani M, Barry M, Boulieu R, Neri B, Seidman E.
    Clin Chem; 2005 Nov 28; 51(11):2074-84. PubMed ID: 16166171
    [Abstract] [Full Text] [Related]

  • 15. Antibodies against infliximab are associated with de novo development of antibodies to adalimumab and therapeutic failure in infliximab-to-adalimumab switchers with IBD.
    Frederiksen MT, Ainsworth MA, Brynskov J, Thomsen OO, Bendtzen K, Steenholdt C.
    Inflamm Bowel Dis; 2014 Oct 28; 20(10):1714-21. PubMed ID: 25069030
    [Abstract] [Full Text] [Related]

  • 16. Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab.
    Yarur AJ, McGovern D, Abreu MT, Cheifetz A, Papamichail K, Deepak P, Bruss A, Beniwal-Patel P, Dubinsky M, Targan SR, Melmed GY.
    Clin Gastroenterol Hepatol; 2023 Oct 28; 21(11):2908-2917.e10. PubMed ID: 36280102
    [Abstract] [Full Text] [Related]

  • 17. Changes in serum trough levels of infliximab during treatment intensification but not in anti-infliximab antibody detection are associated with clinical outcomes after therapeutic failure in Crohn's disease.
    Steenholdt C, Bendtzen K, Brynskov J, Thomsen OØ, Munck LK, Christensen LA, Pedersen G, Kjeldsen J, Ainsworth MA.
    J Crohns Colitis; 2015 Mar 28; 9(3):238-45. PubMed ID: 25576753
    [Abstract] [Full Text] [Related]

  • 18. The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
    Spencer E, Norris E, Williams C, Dubinsky MC.
    Inflamm Bowel Dis; 2019 Jan 01; 25(1):142-149. PubMed ID: 29920603
    [Abstract] [Full Text] [Related]

  • 19. Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis.
    Lowell JA, Sharma G, Chua V, Ben-Horin S, Swaminath A, Sultan K.
    Dig Dis Sci; 2024 Oct 01; 69(10):3920-3931. PubMed ID: 38877332
    [Abstract] [Full Text] [Related]

  • 20. Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease.
    Poon SS, Asher R, Jackson R, Kneebone A, Collins P, Probert C, Dibb M, Subramanian S.
    J Crohns Colitis; 2015 Aug 01; 9(8):640-6. PubMed ID: 25968584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.